000 01434 a2200397 4500
005 20250512062012.0
264 0 _c19870819
008 198708s 0 0 eng d
022 _a0277-5379
024 7 _a10.1016/0277-5379(86)90091-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Oosterom, A T
245 0 0 _a4'Deoxydoxorubicin in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
_h[electronic resource]
260 _bEuropean journal of cancer & clinical oncology
_cDec 1986
300 _a1531-2 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntibiotics, Antineoplastic
_xtherapeutic use
650 0 4 _aDoxorubicin
_xanalogs & derivatives
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
700 1 _aBono, A V
700 1 _aKaye, S B
700 1 _aSplinter, T A
700 1 _aCalciati, A
700 1 _aFosså, S D
700 1 _ade Pauw, M
700 1 _aSylvester, R
773 0 _tEuropean journal of cancer & clinical oncology
_gvol. 22
_gno. 12
_gp. 1531-2
856 4 0 _uhttps://doi.org/10.1016/0277-5379(86)90091-x
_zAvailable from publisher's website
999 _c3601392
_d3601392